1、06/1 0/2022INDEPENDEN T P U B L I C AT I O N BY#0836R AC O N T EU R.NE TLife Sciences Superpower:Growing the leading global hub in the UKRead the latest report on the potential for life sciences to create health and wealth for the UK.FUTURE OFPHARMACEUTICALSHOW GLASGOWS R&D HUB CAN AID THE NHSBREAKI

2、NG THE IRON GRIP OF EROOMS LAW0403COULD 3D PRINTING TRANSFORM PHARMA?10R A C O N T E U R.N E TF U T U R E O F P H A R M A C E U T I C A L S0302pioneering new R&D facility,to be officially opened shortly,is set to streamline pharmaceutical production in the UK.Experts in the field believe that the wo

3、rk of the 56m Medicines Manufacturing Innovation Centre(MMIC)has the potential to save the economy hundreds of millions of pounds a year.The centre,located by Glasgow Airport,is the outcome of a public private collaboration involving founding industry partners GSK and AstraZeneca,Scottish Enterprise

4、,UK Research and Innovation,the Centre for Process Innovation and the University of Strathclyde.Professor Clive Badman,executive director at the university and former head of precompetitive collaboration at GSK,has played a leading role in the centres creation.He explains that one of the main reason

5、s for its existence is to find a more efficient alternative to whats been the industrys standard procedure for the past 100 years:multistep batch manufacturing.The stopstart nature of this approach means that the entire production process can take as long as two years.If producers were to adopt soca

6、lled continuous manufacturing on a large scale instead,it should enable them to cut the time down to six months at most.Batch manufacturing is notoriously inefficient.In a research report last year,PwC noted that,15 years ago,“it was estimated that$50bn was lost as waste each year in the US alone du